期刊文献+

口服避孕药预处理在体外受精-胚胎移植促性腺激素释放激素拮抗剂方案使用中的临床应用 被引量:6

Pretreatment of oral contraceptive before GnRH antagonist protocol during in vitro fertilization-embryo transfer
下载PDF
导出
摘要 目的比较分析体外受精-胚胎移植(IVF-ET)周期应用促性腺激素释放激素(GnRH-ant)拮抗剂方案中用或未用口服避孕药(达英-35)预处理患者的临床特征和治疗结局。方法回顾性分析252个IVF-ET移植周期,分为3组,A组:116例,达英-35预处理GnRH-ant方案移植周期组;B组:46例,未用达英-35预处理GnRH-ant方案移植周期组;C组:90例,GnRH-a长方案移植周期组。比较各组患者的年龄、促性腺激素(Gn)使用天数和剂量、HCG日LH水平、取卵日内膜厚度、可用胚胎率、临床妊娠率等。结果 A组平均年龄(30.9±0.8)较B组(33.9±1.7)年轻,有显著性差异(P<0.05);A组Gn使用天数和用量比B组多,但无显著性差异(P>0.05);A组HCG日LH水平和取卵日内膜厚度均较B组显著减少(P<0.05);A组与B组的可用胚胎率无显著性差异(P>0.05);A组临床妊娠率(18.1%)较B组(37.0%)显著下降(P<0.05);B组临床妊娠率(37.0%)与C组(38.8%)相比较无显著性差异(P>0.05)。结论在IVF-ET治疗中应用口服避孕药预处理GnRH-ant方案,妊娠率显著下降,但未用口服避孕药预处理的GnRH-ant方案,能获得满意的临床结局。 Objective: To analyze the clinical features and outcome of patients who used or did not used oral contraceptive (Diane-35)pretreatment before gonadotropin releasing hormone antagonist (GnRH-ant) protocol during in vitro fertilization-embryo transfer(IVF-ET)cycles. Methods: All the IVF-ET cycles were divided to three groups. The patients in group A(n= 116)used oral contraceptive before GnRH-ant treatment. The patients in group B(n= 46)did not used oral contraceptive before GnRH-ant treatment. The patients in group C(n= 90)were applied with GnRH agonist(GnRH-a)long protocol cycle. Patient's age, dose and duration of gonadotropin treatment, serum LH levels on HCG day, endometrial thickness,clinical pregnancy rate etc. were compared among the three groups. Results: The patients' age in group A were significantly younger than group B(30.9±0.8 vs. 33.9± 1.7) (P〈0.05). The dose and duration of gonadotropins(Gn)used in group A were higher than those in group B(P〉0.05). The serum LH and the endometrial thickness in group A were significantly lower than those in group B(P〈0.05). There were no significant differences in good quality embryos rates among the three groups. The clinical pregnancy rate in group A significantly decreased (18.0% vs. 37.0%)(P〈0.05). There was no significant difference in clinical group B and group C(37.0% vs. 38.8%). However the dose and duration significantly less than those in group C. compared with group B pregnancy rates between of Gn in Group B were Conclusions. Usage of oral contraceptive before GnRH-ant protocol significantly decreases pregnancy rate. However,GnRH-ant protocol without oral contraceptive pretreatment can get a comparable clinical outcome with GnRH-a long protocol.
作者 黄品秀 李蓉
出处 《生殖医学杂志》 CAS 2014年第4期296-300,共5页 Journal of Reproductive Medicine
关键词 体外受精 胚胎移植 促性腺激素释放激素拮抗剂 口服避孕药 达英-35 In vitro fertilization Embryo transfer Gonadotropin-releasing hormone antagonist Oral contraceptive Diane-3
  • 相关文献

参考文献11

  • 1Kim CH,Moon JW, Kang HJ, et al. Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF/ICSI [J]. Clin Exp Reprod Med, 2012,39 : 22-27. 被引量:1
  • 2Luna M, Vela G, McDonald CA, et al. Results with GnRH .i antagonist protocols are equivalent to GnRH agonist protocols in comparable patient populations [J]. J Reprod Med,2012,57:123-128. 被引量:1
  • 3Steer CV, Mills CL, Tan SL, et al. The cumulative embryo score: a predictive embryo scoring technique to select the optimal number of embryos to transfer in an in-vitro fertilization and embryo transfer programme [J]. Hum Reprod,1992,7:117-119. 被引量:1
  • 4Garcia-Velasco JA, Bermejo A, Ruiz F, et al. Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocoha randomized,controlled trial [J]. Fertil Steril, 2011,96 : 590-593. 被引量:1
  • 5Pinkas H, Sapir O, Avrech OM, et al. The effect of oral contraceptive pill for cycle scheduling prior to GnRH- antagonist protocol on IVF cycle parameters and pregnancy outcome [J]. J Assist Reprod Genet, 2008,25 : 29-33. 被引量:1
  • 6Kolibianakis EM,Papanikolaou EG,Camus M,et al. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial [J]. Hum Reprod,2006,21:352-357. 被引量:1
  • 7Griesinger G, Kolibianakis EM, Venctis C, et al, Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles:an updated recta-analysis [J]. Fertil Steril, 2010,94 : 2382-2384. 被引量:1
  • 8Decanter C, Robin G, Thomas P, et al. First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome? [J]. Reprod Biol Endocrinol, 2 013,11 : 54. 被引量:1
  • 9Sehmitz C, Bocea S, Beydoun H, et al. Does the degree of hypothalamic-pit uitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35 years of age? [J]. J Assist Reprod Genet, 2012, 29: 877-882. 被引量:1
  • 10王冬颖,田莉,戴林,杨振娟.多囊卵巢综合征患者达英-35治疗后不同间隔启动促排卵的妊娠结局[J].中国妇产科临床杂志,2009,10(2):134-137. 被引量:8

二级参考文献25

  • 1陆湘,汪玉宝,张炜,薛晓红.达英35对非肥胖、非胰岛素抵抗多囊卵巢综合征胰岛素敏感性的影响[J].实用妇产科杂志,2004,20(6):340-342. 被引量:25
  • 2邵明君,叶碧绿,赵军招,林金菊,林文琴,黄学锋.体外受精-胚胎移植在多囊卵巢综合征不育患者中的应用[J].生殖医学杂志,2005,14(1):10-12. 被引量:20
  • 3陈子江,李媛,赵力新,姜晶晶,唐蓉,盛燕,高芹,张中和.超声下未成熟卵泡抽吸术治疗多囊卵巢综合征不孕的临床研究[J].中华妇产科杂志,2005,40(5):295-298. 被引量:83
  • 4Gonen Y,Jacobson W,Casper RF.Gonadotropin suppression with oral contraceptives before in vitro fertilization.Fertil Steril,1990,53:282-287. 被引量:1
  • 5Palomba S,Falbo A,Negro S,et al.Use of oral contraceptives in infertile patients:A descriptive review.Gynecological Endocrinology,2006,22:537-546. 被引量:1
  • 6Kolibianakis EM,Papanikolaou EG,Camus M,et al.Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF.A randomized controlled trial.Hum Reprod,2006,21:352-357. 被引量:1
  • 7Rombauts L,Healy D,Norman RJ.orgalutran scheduling Study Group.A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients.Human Reproduction,2006,21:95-103. 被引量:1
  • 8The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.Hum Reprod,2004,19:41-47. 被引量:1
  • 9Hastings JM,Licence DR,Burton GJ,et al.Soluble Vascular Endothelial Growth Factor Receptor 1 Inhibits Edema and Epithelial Proliferation Induced by 17-Estradiol in the Mouse Uterus.Endocrinology,2003,144:326-334. 被引量:1
  • 10Duvan CI,Berker B,Turhan NO,et al.Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patients.J Assist Reprod Genet,2008,25:89-93. 被引量:1

共引文献10

同被引文献57

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部